CD59 and posterior cortical atrophy: Our findings highlight the importance of Siglec-7/9 expression and their interactions with sialic acids on Siglec-7/9 ligands in PCa progression and suggest potential therapeutic targets including CD59/Siglec-9 for immune-based therapeutic interventions.